Donna Finch is Alchemab’s Head of Translational and Clinical Science where she oversees our target discovery and validation activities and our non-clinical and early clinical development efforts.

Prior to joining Alchemab, Donna was Associate Director, Respiratory Inflammation and Autoimmunity, R&D Biopharmaceuticals at MedImmune and AstraZeneca, leading pre-clinical biology, translational and early clinical activities of several projects from conception through Phase 2 clinical development. Prior to MedImmune, Donna held several positions of increasing responsibility at Cambridge Antibody Technology, mainly responsible for Pharmacology.

Donna earned a PhD in Molecular Pharmacology from Leicester University and a BSc in Pharmacology from Bristol University and has an extensive publication and patent record.